Dr Isaac Edward Wenger, MD in Bay Shore, NY - Medicare Student in an Organized Health Care Education/Training Program

Dr Isaac Edward Wenger, MD is a medicare enrolled "Student In An Organized Health Care Education/training Program" physician in Bay Shore, New York. His current practice location is 301 E Main St, Bay Shore, New York. You can reach out to his office (for appointments etc.) via phone at (631) 358-5943.

Dr Isaac Edward Wenger is licensed to practice in * (Not Available) (license number ) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1952976714.

Contact Information

	Dr Isaac Edward Wenger, MD
	301 E Main St, Bay Shore, NY 11706-8408
	(631) 358-5943
	Not Available

Physician's Profile

Full Name	Dr Isaac Edward Wenger
Gender	Male
Speciality	Student In An Organized Health Care Education/training Program
Location	301 E Main St, Bay Shore, New York
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1952976714
Provider Enumeration Date: 05/24/2021
Last Update Date: 06/21/2022

Medicare PECOS Information:

PECOS PAC ID: 4587065255
Enrollment ID: I20210701002031

Medical Identifiers

Medical identifiers for Dr Isaac Edward Wenger such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1952976714	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208600000X	Surgery	MT222707 (Pennsylvania)	Secondary
390200000X	Student In An Organized Health Care Education/training Program	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Isaac Edward Wenger is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Isaac Edward Wenger, MD 301 E Main St, Bay Shore, NY 11706-8408 Ph: (561) 213-7883	Dr Isaac Edward Wenger, MD 301 E Main St, Bay Shore, NY 11706-8408 Ph: (631) 358-5943

News Archive

DDT in Alaskan fish shown to increase risk of cancer

A new study has found that children in Alaska who consume a lot of fish from rivers fed by the Eastern Alaska Mountain Range may be at an increased risk of cancer.

Velcade (bortezomib) phase III clinical trial initiated in patients with newly diagnosed multiple myeloma

Millennium Pharmaceuticals today announced, in collaboration with Johnson & Johnson Pharmaceutical Research & Development, LLC, the initiation of VISTA (Velcadeas Initial Standard Therapy in multiple myeloma: Assessment with melphalan and prednisone), a multicenter, international phase III clinical trial of Velcadein combination with melphalan and prednisone versus melphalan and prednisone in patients with newly diagnosed multiple myeloma (MM) who are not transplant candidates.

Implantable cardiac monitors effectively detect serious arrhythmias in selected post-infarction patients

Remote monitoring of implantable cardiac monitors (ICMs) is highly effective for early detection of serious arrhythmias in high-risk post-infarction patients with cardiac autonomic dysfunction and moderately reduced ejection fraction.

New York Times examines emergence of XDR-TB in Australia, PNG

"Australia's first death from XDR-TB - extensively drug-resistant tuberculosis, which is nearly incurable - has alarmed health officials and added new heat to a debate over how to treat immigrants with dangerous diseases," the New York Times reports.

Columbia closes sale of progesterone related assets and 11.2M shares to Watson

Columbia Laboratories, Inc. announced today that it has closed the sale of its progesterone related assets and 11.2 million shares of common stock to Watson Pharmaceuticals, Inc.. Columbia's business now consists of its royalty and manufacturing revenues, potential milestone payments, its collaboration with Watson on the development of next-generation progesterone products, and its novel bioadhesive drug delivery technologies and other products.

Dr Isaac Edward Wenger, MD - Medicare Student in an Organized Health Care Education/Training Program in Bay Shore, NY